Laboratory Products 43


Smart Dual Evaporator Supports Sample Preparation Workflows Biotage is pleased to announce the launch of a sophisticated well plate evaporator, the TurboVap®


building upon the reputable foundation of the Biotage TurboVap® The new TurboVap®


product line.


96 Dual has been designed to support enhanced well-plate evaporation within the sample preparation workflow. With its unique two in one functionality users can run the same method on two plates simultaneously, or two independent evaporations, essentially doubling throughput. The capability to act as two single units and a dual, enabling laboratories an opportunity to balance their evolving sample throughput needs.


TurboVap®


96 Dual is dedicated to the evaporation of solvents in 24, 48, or 96 well plate array formats the new system can evaporate solvent levels from microlitres up to 10 mL per well. The system applies user controlled heated nitrogen from the top, while simultaneously heating the bottom of the well plate by convection. Evaporated solvent vapours are contained and evacuated under negative pressure.


TurboVap®


96 Dual monitors both energy and gas consumption for each evaporation cabinet, so laboratories can accurately manage and forecast their future requirements. The systems small footprint easily fits inside a standard chemical fume hoods and the integral touchscreen further reduces its footprint when compared to the classic TurboVap®


“The introduction of the new TurboVap® 96 Dual reinvents evaporation, placing the customer in full control of an intelligent and smart evaporation system. Proof positive of our


commitment to HumanKind Unlimited, making the world healthier, greener and cleaner,” said Tomas Blomquist, CEO Biotage. More information online: ilmt.co/PL/9pBn


57139pr@reply-direct.com


Time Critical Delivery of Biowaste Decontamination Systems Completed at UK COVID-19 Vaccine Production Facility


Suncombe has designed, built and delivered high specification biowaste effluent decontamination systems (EDS) in an extremely short timeframe to support the expanding Covid-19 vaccine production programme of a global manufacturer in the United Kingdom. To complete this work the company has constructed new vaccine production areas, each of which required a dedicated decontamination system for BSL3 biowaste.


Normally BSL3 decontamination systems need to be housed within secure containment rooms. However, due to the fast-track nature of this project, there was no time for a specially built containment area to be incorporated into the facility. So Suncombe proposed that the decontamination systems could each be mounted in purpose-built containerised modules, with full containment barriers built within the containers.


The biowaste EDS were built and tested inside containerised modules, including the process equipment. These modules also incorporate containment barriers, a washing facility, lobby, safe change HEPA air filtration, door locks and other features, all essential requirements for a BSL3 biowaste treatment system.


An advanced BioSuite#3000 software package was added. This was developed by Suncombe engineers and is suitable for full validation, incorporating 21CFR part 11 compliance, user levels and an audit trail, to control all of the equipment.


Construction started prior to the completion of detailed design, in order to achieve the very fast timescale. The initial design methodology was agreed which enabled construction to be started, while allowing the process development to continue.


This project, was carried out with the backdrop of COVID-19 measures, which affected the ability to secure materials and also impacted on working patterns, such as social distancing and increased hygiene, to ensure the safety of the company’s workforce.


Two containerised systems have recently been delivered following extensive testing to ensure a ‘plug ‘n’ play’ start up when arriving on site.


“Suncombe was able to improve on the promised timescales and deliver ahead of schedule,” explained Operations Director, Steve Overton. “We are delighted to have been able to get involved in this new vaccine production facility and to employ our 60 years of experience, extensive knowledge and ‘can do’ attitude to help in the COVID-19 pandemic,” he added. More information online: ilmt.co/PL/9pW5


57259pr@reply-direct.com Tips and Tricks for Precision Pipetting


Correct liquid handling techniques ensure consistently high reproducibility and reliability, yet some researchers still have bad habits that lead to inconsistencies, even if protocols are performed the same way every time. While the emphasis of quality assurance measures has typically been on pipette calibration, repair and maintenance, ensuring consistent pipetting technique is just as pivotal to the efficiency of workflows and the success of projects.


A new series of videos is available from Integra Biosciences to help life sciences researchers improve pipetting accuracy and precision. Distilling decades of combined experience into easy-to-follow guides, these videos are designed to help researchers understand when and how to use both manual and electronic pipettes, as well as covering techniques for pre-wetting, ‘problem liquids’ and basic pipette maintenance.


This new video series highlights the factors operators need to consider to ensure results are not affected by common liquid handling errors. For example, when and where to use manual or electronic pipettes, how and when to properly pre-wet pipette tips to reduce liquid loss, the importance of maintaining a consistent pipetting angle during each aspiration, as well as when these rules don’t apply! The series also covers regular maintenance – another key factor to ensure the highest accuracy and precision for the lifespan of your pipette – including how to store when not in use, regular cleaning practices, leak testing and calibrations.


Visit the Integra Biosciences website to watch the entire video series and download a pipetting tips and tricks poster for your lab workspace. More information online: ilmt.co/PL/v639


Global Campaign Supports Problem-free Pharmaceutical Production


A campaign promoting problem-free pharmaceutical production has been launched by world leading empty hard-shell capsules producer, ACG. Through this campaign - ACG loves nothing’ - the company aims to significantly improve pharmaceutical production through collaboration and industry-leading innovation. With a host of value-added services on offer, ACG has taken a pledge to strive for zero-problem pharmaceutical and nutraceutical manufacturing.


Alex Robertson, CMO at ACG, said: “The messaging at the centre of this campaign is: ‘ACG loves nothing’ - we are putting every effort towards zero-problem production. That’s because when ‘nothing’ happens during pharmaceutical and nutraceutical production, everything runs reliably, and our customers can get the products they make to the people who need them. We will achieve this by providing the highest quality empty capsules and all the holistic advice and expertise required for seamless operations.”


Founded 60 years ago, ACG was created on the simple principle of ‘Make it Better’. As the world’s largest integrated supplier of solid dosage pharmaceutical and nutraceutical products, and with the most comprehensive ranges of vegetarian and gelatin capsules globally, ACG has the scale and range to have a far-reaching impact on nutraceutical production and human health.


Selwyn Noronha, CEO ACG Capsules, added: “The pharmaceutical sector is regulated and highly competitive. Companies operating within it need a diverse range of quality capsules that help them stand out from the crowd, while also meeting demands for clean and natural products.


“Beyond exceptional products, these companies need expertise and a lifetime of targeted support to ensure efficient manufacturing and guarantee regulatory compliance. With proficiency in all aspects of manufacturing from capsules to machines and protective barriers, for the last 60 years ACG has been the only company to offer this level of support, and it continues with this focus at the heart of operations.”


So, at ACG, there really is something about nothing. The company is on a mission to drive towards problem free production and collaborating with its customers to collectively deliver on its mission of creating a healthier world.


More information online: ilmt.co/PL/pkMA 57230pr@reply-direct.com 57249pr@reply-direct.com systems. 96 Dual - a second-generation system with two separate, and independently controlled evaporation compartments,


WWW.LABMATE-ONLINE.COM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52